Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...

Author

Jen Farmer

This email address is being protected from spambots. You need JavaScript enabled to view it.

Chief Executive Officer

Title Created Date Category
E3 Ligase RNF126 Directly Ubiquitinates Frataxin, Promoting Its Degradation: Identification of a Potential Therapeutic Target for Friedreich Ataxia Friday, February 24, 2017 Scientific News
FA Patient Focused Drug Development Meeting - Your opportunity to tell the FDA what is important to you in finding a treatment for Friedreich’s Ataxia Monday, February 20, 2017 News & Press Releases
FA Patient Focused Drug Development Meeting - Your opportunity to tell the FDA what is important to you in finding a treatment for Friedreich’s Ataxia Monday, February 20, 2017 Activities & Events Blog
Biomarkers in FA Friday, February 17, 2017 Clinical Trials - Active - Enrolling
Chondrial Therapeutics Secures Up to $22.6 Million in Series A Financing and Licenses Novel Technology for the Treatment of Friedreich’s Ataxia Monday, February 6, 2017 Scientific News
2nd International Ataxia Research Conference - September 27-30, 2017 - Pisa, Italy Wednesday, February 1, 2017 News & Press Releases
Cardiac transplantation in Friedreich Ataxia: Extended follow-up Tuesday, January 24, 2017 Funded Research
Newly Funded FARA Grants Thursday, January 19, 2017 Scientific News
Friedreich Ataxia: Hypoplasia of Spinal Cord and Dorsal Root Ganglia Tuesday, January 17, 2017 Funded Research
STEADFAST Background for the Friedreich's Ataxia community Monday, January 16, 2017 Scientific News

SHARE

FacebookTwitterLinkedInYoutube
Event D.jpg
Site Map     Privacy Policy      Service Terms      Contact      Charity Navigator